Managing Hodgkin lymphoma without chemotherapy: a novel, yet 'welcomed', challenge

Hampig Raphael Kourie; Samer Tabchi; Joseph Kattan

doi:10.2217/fon-2016-0160

Managing Hodgkin lymphoma without chemotherapy: a novel, yet 'welcomed', challenge

Future Oncol. 2016 Jun;12(12):1435-7. doi: 10.2217/fon-2016-0160. Epub 2016 Apr 27.

Authors

Hampig Raphael Kourie^{1

2}, Samer Tabchi^{1

3}, Joseph Kattan¹

Affiliations

¹ Oncology Department, Saint Joseph University, Beirut, Lebanon.
² Oncology Department, Jules Bordet Institute, Brussels, Belgium.
³ Hematology-Oncology Department, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.

PMID: 27117227
DOI: 10.2217/fon-2016-0160

No abstract available

Keywords: Hodgkin's lymphoma; brentuximab vedotin; challenge; checkpoint inhibitors; chemotherapy; ethics; ipilimumab; nivolumab; targeted therapies; trials.

Publication types

Editorial

MeSH terms

Antineoplastic Agents / therapeutic use*
Hodgkin Disease / drug therapy*
Humans
Immunotherapy / methods*
Molecular Targeted Therapy / methods*

Substances

Antineoplastic Agents